The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

23 Jan 2017 07:00

RNS Number : 7780U
Spectra Systems Corporation
23 January 2017
 

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Chief Financial Officer

Spectra Systems, a leading supplier of authentication technology for banknotes, brand authentication and tax stamps, is delighted to announce that, subject to the satisfactory conclusion of due diligence, it has agreed to appoint Brian E McLain C.P.A. (aged 41) as its new Chief Financial Officer.

Brian McLain started his career in 1997 at Arthur Andersen prior to working as a senior accountant at Excelergy Corporation, a software business, located in Lexington, MA from 2000 until 2003. Until late 2006, he then progressed through various roles at International Power, a UK owned power producer located in Marlborough MA, prior to joining SeraCare Life Sciences, Inc, a manufacturer of biological products for the diagnostics and drug discovery markets located in Milford MA. At SeraCare, which was quoted on NASDAQ prior to being bought out in 2012, he progressed from the role of Corporate Controller to Vice President, Finance & Business Solutions. In 2014, he then joined OMNIlife Science Inc., a manufacturer and distributor of orthopaedic devices located in Raynham, MA, in the role of Corporate Controller.

A further announcement will be made upon the conclusion of due diligence by certain of Spectra's customers and the completion of standard regulatory AIM background checks. This due diligence is expected to be completed by no later than February 2017. In the meantime, Doug Anderson, the previous Chief Financial Officer is continuing to assist Spectra as necessary.

Brian McLain joined SeraCare Life Sciences Inc. ("SeraCare") in January 2007, at which point it was already in a bankruptcy process. All creditors were subsequently settled and SeraCare exited the bankruptcy process. There are no other matters which are required to be announced pursuant to paragraph (g) of Schedule 2 to the AIM Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Brian to Spectra Systems and believe that his extensive financial experience in both private and public businesses as well as his experience in technology driven companies will be of immense value to us."

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEFFWSFWSEFF
Date   Source Headline
4th Nov 20145:51 pmRNSHolding(s) in Company
20th Oct 20147:00 amRNSAGM Postponement
30th Sep 20147:00 amRNSInterim results
10th Sep 20149:42 amRNSTR-1: Notification of major interest in shares
1st Sep 20147:00 amRNSNotice of AGM
24th Jul 20147:00 amRNSPartnership with Cool Clean Technologies
22nd Jul 20147:00 amRNSContract wins
24th Jun 20148:15 amRNSPosting of Annual Report and Accounts
23rd Jun 20147:00 amRNSCentral Bank testing Spectra's Aeris technology
20th Jun 20147:00 amRNSSettlement of lawsuit and termination of agreement
12th Jun 20147:00 amRNSTesting of Soiled Banknote Technology
9th May 20147:00 amRNSTR-1: Notification of major interest in shares
30th Apr 20147:00 amRNSPreliminary Results
16th Apr 20143:46 pmRNSTR-1: Notification of major interest in shares
25th Mar 20147:01 amRNSTR-1: Notification of major interest in shares
3rd Mar 20147:00 amRNSCompletion of Acquisition of Inksure Technologies
4th Feb 20143:33 pmRNSTR-1: Notification of major interest in shares
30th Jan 20147:00 amRNSTrading Update
16th Jan 20147:00 amRNSFirst Commercial Orders for Manufacturing Facility
13th Jan 20147:00 amRNSExtension of InkSure Asset Purchase Agreement
13th Jan 20147:00 amRNSSecond G8 Central Bank Test Program
19th Nov 20137:00 amRNSJudgment Reducing Potential Lawsuit Exposure
14th Nov 20137:00 amRNSApproval to deliver suite of sensors worth $8m
2nd Oct 20137:00 amRNSAcquisition of Assets from InkSure Technologies
1st Oct 20137:00 amRNSResult of AGM
27th Sep 20137:00 amRNSInterim Results
27th Aug 20137:00 amRNSNotice of AGM
30th Jul 20137:00 amRNSLarge Order from Central Bank
28th Jun 20137:00 amRNSPosting of Annual Report
2nd Apr 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSRemoval of Restrictions from Common Stock
18th Feb 20137:00 amRNSPre-Close Trading Update
18th Dec 20127:00 amRNSRemoval of Restrictions From Common Stock
17th Dec 20127:00 amRNSAGM Postponement
28th Nov 20127:00 amRNSNotice of AGM
28th Nov 20127:00 amRNSDirector Shareholding
27th Nov 20127:00 amRNSRemoval of Restictions From Common Stock
13th Nov 20127:00 amRNSRemoval of Restrictions From Common Stock
1st Nov 20127:00 amRNSDirector Shareholding
31st Oct 20127:00 amRNSDirector Shareholding
23rd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
16th Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
2nd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
28th Sep 20127:00 amRNSInterim results for the 6 months ended 30 Jun 2012
27th Sep 20127:00 amRNSNew Contract Agreement
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.